Latest / Research To Practice | Oncology Videos
Acute Myeloid Leukemia — An Interview with Dr Jorge Cortes on Optimal Management of FLT3 and IDH1/2 Mutations
Featuring an interview with Dr Jorge Cortes, including the following topics:
Overview of common molecular profiles in newly diagnosed acute myeloid leukemia (AML) (0:00)
Clinical presentation of AML with a FLT3 mutation; implications of clinical data from the Phase III RATIFY trial of the FLT3 inhibitor midostaurin (5:38)
Potential incorporation of a FLT3 inhibitor with azacitidine/venetoclax for transplant-ineligible patients with FLT3-mutant AML (10:32)
Clinical benefit with quizartinib for patients with FLT3-like genetic profile; selection of FLT3 inhibitor as a component of initial…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.